Variant report
| Variant | rs9808229 |
|---|---|
| Chromosome Location | chr2:20431545-20431546 |
| allele | A/C |
| Outlinks | Ensembl UCSC |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr2:20426000-20447000 | Weak transcription | GM12878-XiMat | blood |
| 2 | chr2:20426200-20436600 | Weak transcription | Pancreas | Pancrea |
| 3 | chr2:20426400-20436800 | Enhancers | Placenta | Placenta |
| 4 | chr2:20427400-20431800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
| 5 | chr2:20430400-20431600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
| 6 | chr2:20430400-20432200 | Enhancers | HMEC | breast |
| 7 | chr2:20430600-20432800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
| 8 | chr2:20430800-20431800 | Enhancers | Esophagus | oesophagus |
| 9 | chr2:20430800-20431800 | Enhancers | NHDF-Ad | bronchial |
| 10 | chr2:20430800-20432600 | Enhancers | Stomach Mucosa | stomach |
| 11 | chr2:20431000-20431600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
| 12 | chr2:20431000-20431600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
| 13 | chr2:20431000-20431600 | Enhancers | Colonic Mucosa | Colon |
| 14 | chr2:20431000-20431800 | Genic enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
| 15 | chr2:20431000-20431800 | Enhancers | Lung | lung |
| 16 | chr2:20431000-20431800 | Enhancers | A549 | lung |
| 17 | chr2:20431000-20431800 | Flanking Active TSS | HepG2 | liver |
| 18 | chr2:20431000-20431800 | Enhancers | NH-A | brain |
| 19 | chr2:20431000-20431800 | Enhancers | NHLF | lung |
| 20 | chr2:20431000-20432000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
| 21 | chr2:20431000-20433000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
| 22 | chr2:20431000-20433000 | Enhancers | H1 Cell Line | embryonic stem cell |
| 23 | chr2:20431000-20433000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
| 24 | chr2:20431000-20433000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
| 25 | chr2:20431000-20433000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
| 26 | chr2:20431000-20433400 | Enhancers | Placenta Amnion | Placenta Amnion |
| 27 | chr2:20431200-20431600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
| 28 | chr2:20431200-20431600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
| 29 | chr2:20431200-20431600 | Enhancers | Gastric | stomach |
| 30 | chr2:20431200-20431800 | Enhancers | H9 Cell Line | embryonic stem cell |
| 31 | chr2:20431200-20431800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
| 32 | chr2:20431200-20431800 | Enhancers | Fetal Intestine Large | intestine |
| 33 | chr2:20431200-20431800 | Enhancers | Fetal Intestine Small | intestine |
| 34 | chr2:20431200-20431800 | Enhancers | HUVEC | blood vessel |
| 35 | chr2:20431200-20432800 | Flanking Active TSS | NHEK | skin |
| 36 | chr2:20431400-20431600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
| 37 | chr2:20431400-20431800 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
| 38 | chr2:20431400-20431800 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
| 39 | chr2:20431400-20431800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
| 40 | chr2:20431400-20432000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
| 41 | chr2:20431400-20432000 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
| 42 | chr2:20431400-20432000 | Flanking Active TSS | Hela-S3 | cervix |
| 43 | chr2:20431400-20432600 | Enhancers | Duodenum Mucosa | Duodenum |
| 44 | chr2:20431400-20435600 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
| 45 | chr2:20431400-20446800 | Weak transcription | Spleen | Spleen |
